In one of what will surely be recalled as one of this century’s greatest rebrandings, the failed rumbledrug Brawlwell III – a potent if messy cocktail of adrenergic-analogs whose unfortunate side-effects (including nausea, tachycardia, shortness of breath, sweating, trembling, xerostomia, and impaired decision-making abilities) rendered it unsuitable, or at least rather unwise, to use under combat conditions – has now passed an estimated trillion units sold since its various independent manufacturers renamed it Terror Alert Red and marketed it as a hedonic catering to those who wish to experience “authentic fear” under controlled conditions.
Well played, gentlesophs. While not eligible for a formal award, we at the Meta-Marketing Monitor salute you!
– a letter published in the Independent Worlds Router
